Prostate Cancer

Radioligand Therapy for Prostate Cancer: The New Kid on the Block

A promising new treatment is changing the landscape for advanced prostate cancer. In this episode, Dr. Bill Evans is joined by Dr. Ali Khan Lalani, Associate professor, McMaster University GU disease site team chair, Juravinski Cancer Centre, and Anne Khoorshed, Radiation Safety Officer, Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton, to explore radioligand therapy (Pluvicto), an innovative targeted treatment now available in Hamilton. They break down how this “smart bomb” approach works, who may be eligible, what patients can expect, and why this advancement is bringing new hope to men with advanced prostate cancer. From improved quality of life to exciting future research, this conversation offers an accessible look at one of cancer care’s most promising emerging therapies.

Prostate Cancer: What Have We Learned?

Join us for this important discussion with Dr. Sebastian Hotte. In this episode, we discuss changes in how prostate cancer is diagnosed and treated. Listen in as we talk about new treatments that are available, and how these treatments are performed.